Lili X. Qiao
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration.
Journal: Translational lung cancer research
Published: April 12, 2026
Macrophages in lung cancer: principal factors, regulatory mechanisms, and therapeutic opportunities: a narrative review.
Journal: Translational lung cancer research
Published: April 03, 2026
Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 01, 2026
Development and validation of nomograms integrating electrolyte, nutritional, and inflammatory indicators to predict survival in advanced esophageal cancer undergoing immunotherapy or radioimmunotherapy.
Journal: Journal of thoracic disease
Published: February 08, 2026
Contribution of immune cells and cytokines to radiation-induced injury: the key roles and potential targets.
Journal: Frontiers in immunology
Published: January 12, 2026
Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future directions.
Journal: Translational lung cancer research
Published: January 05, 2026
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy.
Journal: Cancer medicine
Published: November 05, 2025
Efficacy and safety of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma patients with pathologic incomplete response after neoadjuvant immunochemotherapy: a retrospective cohort study.
Journal: Frontiers in immunology
Published: July 05, 2025
The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real-world study.
Journal: Frontiers in immunology
Published: January 05, 2025
Unraveling the Oncogenic Characteristics of the Cytolinker, Plectin, in Esophageal Squamous Cell Carcinoma.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 16, 2024
Impact of postmastectomy radiotherapy on locoregional recurrence and survival in patients with ypN0 breast cancer after neoadjuvant chemotherapy: A comprehensive meta-analysis and systematic review.
Journal: Journal of cancer research and therapeutics
Published: July 04, 2024
Last Updated: 09/26/2026